These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25255772)

  • 1. Thrombotic thrombocytopenic purpura following terbinafine therapy.
    Filanovsky K; Sigler E; Shvidel L
    J Clin Apher; 2015 Feb; 30(1):58-9. PubMed ID: 25255772
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombotic thrombocytopenic purpura associated with statin therapy.
    Thomas MR; McDonald V; Machin SJ; Scully MA
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):762-3. PubMed ID: 22198366
    [No Abstract]   [Full Text] [Related]  

  • 3. [The clinical significance of ADAMT13 antigen change in thrombotic thrombocytopenic purpura patients by plasma exchange treatment].
    Yang P; Li YP; Wen HQ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):879-80. PubMed ID: 23384919
    [No Abstract]   [Full Text] [Related]  

  • 4. Full evaluation of an acquired case of thrombotic thrombocytopenic purpura following the surgical resection of glioblastoma multiforme.
    Cataland SR; Jin M; Smith E; Stanek M; Wu HM
    J Thromb Haemost; 2006 Dec; 4(12):2733-7. PubMed ID: 16972936
    [No Abstract]   [Full Text] [Related]  

  • 5. Current management of thrombotic thrombocytopenic purpura.
    Kremer Hovinga JA; Meyer SC
    Curr Opin Hematol; 2008 Sep; 15(5):445-50. PubMed ID: 18695366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of rituximab and concurrent plasma exchange in the treatment of thrombotic thrombocytopenic purpura.
    Hull MJ; Eichbaum QG
    Clin Adv Hematol Oncol; 2006 Mar; 4(3):210-4; discussion 217-8. PubMed ID: 16728930
    [No Abstract]   [Full Text] [Related]  

  • 7. Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor.
    Pandey S; Nakagawa M; Rosenbaum ER; Arnaoutakis K; Hutchins LF; Makhoul I; Milojkovic N; Cottler-Fox M
    J Clin Apher; 2015 Feb; 30(1):50-4. PubMed ID: 25042026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.
    Peyvandi F; Lavoretano S; Palla R; Feys HB; Vanhoorelbeke K; Battaglioli T; Valsecchi C; Canciani MT; Fabris F; Zver S; Réti M; Mikovic D; Karimi M; Giuffrida G; Laurenti L; Mannucci PM
    Haematologica; 2008 Feb; 93(2):232-9. PubMed ID: 18223285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura.
    Moore JC; Arnold DM; Leber BF; Clare R; Molnar GJ; Kelton JG
    Vox Sang; 2007 Aug; 93(2):173-5. PubMed ID: 17683362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful management of thrombotic thrombocytopenic purpura in a Jehovah's Witness without plasma exchange.
    Chai W; Chaudhry A; Rabinowitz AP
    J Clin Apher; 2015 Feb; 30(1):46-9. PubMed ID: 24782109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity.
    Cataland SR; Jin M; Lin S; Kennedy MS; Kraut EH; George JN; Wu HM
    Br J Haematol; 2007 Nov; 139(3):486-93. PubMed ID: 17910638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role for adjunctive treatment to plasma exchange in thrombotic thrombocytopenic purpura.
    Thachil J
    Nephrol Dial Transplant; 2008 Aug; 23(8):2701-2; author reply 2702-3. PubMed ID: 18403435
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombotic thrombocytopenic purpura--the role of ADAMTS13 assay in clinical practice.
    Duraković N; Radonić R; Gasparović V
    Coll Antropol; 2010 Sep; 34(3):1087-91. PubMed ID: 20977108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma.
    Isonishi A; Bennett CL; Plaimauer B; Scheiflinger F; Matsumoto M; Fujimura Y
    Transfusion; 2015 Oct; 55(10):2321-30. PubMed ID: 26058519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial ADAMTS13 measurements during initial plasma exchange therapy guide decisions for management of unresponsive thrombotic thrombocytopenic purpura.
    van der Veen BS; Besseling R; Hoogendoorn M
    Transfusion; 2015 Oct; 55(10):2511-5. PubMed ID: 26308736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent thrombotic thrombocytopenic purpura treated repeatedly and successfully with the monoclonal antibody rituximab.
    Herbei L; Venugopal P
    Clin Adv Hematol Oncol; 2006 Mar; 4(3):215-7; discussion 217-8. PubMed ID: 16728931
    [No Abstract]   [Full Text] [Related]  

  • 17. Micafungin-induced thrombotic thrombocytopenic purpura: a case report and review of the literature.
    Nazzal M; Safi F; Arma F; Nazzal M; Muzaffar M; Assaly R
    Am J Ther; 2011 Nov; 18(6):e258-60. PubMed ID: 20335786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura.
    Cataland SR; Jin M; Ferketich AK; Kennedy MS; Kraut EH; George JN; Wu HM
    Br J Haematol; 2007 Jan; 136(1):146-9. PubMed ID: 17069579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic thrombocytopenic purpura and its diagnosis.
    Veyradier A; Meyer D
    J Thromb Haemost; 2005 Nov; 3(11):2420-7. PubMed ID: 15892859
    [No Abstract]   [Full Text] [Related]  

  • 20. Analyses of ADAMTS13 activity and its inhibitor in patients with thrombotic thrombocytopenic purpura secondary to connective tissue diseases: Observations in a single hospital.
    Sato T; Hanaoka R; Ohshima M; Miwa Y; Okazaki Y; Yajima N; Ishizashi H; Matsumoto M; Fujimura Y; Inokuma S
    Clin Exp Rheumatol; 2006; 24(4):454-5. PubMed ID: 16956441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.